Lv3
208 积分 2025-05-09 加入
Eribulin monotherapy versus treatment of physician's choice in patients with metastatic breast cancer (EMBRACE): a phase 3 open-label randomised study
19天前
已完结
Eribulin Mesylate: A Promising New Antineoplastic Agent for Locally Advanced or Metastatic Breast Cancer
29天前
已关闭
Effect of pancreatic exocrine and endocrine insufficiency in cardiovascular events in patients with chronic pancreatitis (CP). A prospective cohort study
1个月前
已完结
Neoadjuvant chemotherapy with FOLFIRINOX and preoperative chemoradiotherapy for patients with locally advanced rectal cancer (UNICANCER-PRODIGE 23): a multicentre, randomised, open-label, phase 3 trial
1个月前
已完结
Eltrombopag for radiation-induced thrombocytopenia in a glioblastoma patient
1个月前
已完结
Efficacy and safety of neoadjuvant pertuzumab and trastuzumab in women with locally advanced, inflammatory, or early HER2-positive breast cancer (NeoSphere): a randomised multicentre, open-label, phase 2 trial
1个月前
已完结
5-year analysis of neoadjuvant pertuzumab and trastuzumab in patients with locally advanced, inflammatory, or early-stage HER2-positive breast cancer (NeoSphere): a multicentre, open-label, phase 2 randomised trial
1个月前
已完结
Ten-year survival of neoadjuvant dual HER2 blockade in patients with HER2-positive breast cancer
1个月前
已完结
Clinical Pharmacology and Use of Laxatives and Lavage Solutions
1个月前
已完结
Rage against the machine? Framing societal threat and efficacy in YouTube videos about artificial intelligence
Sustainable nickel enabled by hydrogen-based reduction
皖公网安备34019202002308
